Press release
CoSign Digital Signatures to Expedite Field Service Reports at MEDRAD
ARX (Algorithmic Research), a leading provider of digital signatures (standard electronic signatures) and information assurance solutions, has been chosen to implement a CoSign® digital signature solution at MEDRAD (a subsidiary of Bayer AG), a worldwide provider of medical devices and services.Approximately 100 field service representatives maintain MEDRAD's cardiovascular and angiography diagnostic and therapeutic imaging medical systems throughout the world. These field reps are required by US Food and Drug Administration (FDA) regulation to generate a signed service report for all field service work performed. MEDRAD's CRM generates these field reports, and multiple copies are then printed for signing. Over the course of a year, tens of thousands of field service reports are generated, signed, shipped, and archived. In order to alleviate such a cost-prohibitive and labor intensive process, MEDRAD decided to implement the use of a digital signature solution, which would allow them to maintain a completely electronic workflow. CoSign's compatibility with all major documentation formats provided the perfect solution to MEDRAD's digital signature needs.
Upon CoSign's full implementation at MEDRAD, the company's field service representatives will document their maintenance work in reports created by the CRM. The report will automatically be turned into a PDF and saved to a folder on their local PC. Later in the week, or when it's convenient, the representative will be able to digitally batch sign all of their reports at once, and have them automatically saved to the network drive in an FDA 21 CFR Part 11-compliant manner. The Cosign digital signature solution will completely eliminate the need to print, sign, ship, and physically archive service reports, reducing a two week process into one that can be completed in a minute.
Rodd Shlerf, Sales Manager at ARX said, "We find that medical device companies have many processes that can benefit from CoSign. Field service reports are a great example of a regulated, large volume, paper-intensive process costing organizations huge amounts of money and more importantly – people’s time."
Angela Gasper, IT Project Manager at MEDRAD explained, "Through our use of CoSign's digital signature solution, MEDRAD expects to significantly cut costs in shipping, paper-related products, and workload." Gasper added that, "Additionally, ARX's experienced technical staff worked closely with us to customize our application for batch signing of reports, allowing our field service representatives to concentrate on work, not paperwork."
About MEDRAD
MEDRAD, Inc. is a worldwide leading provider of medical devices and services that enable and enhance imaging procedures of the human body. Used in diagnostic imaging, MEDRAD's product offerings include a comprehensive line of vascular injection systems, magnetic resonance (MR) surface coils and accessory products, and equipment services. MEDRAD is a recipient of the 2003 Malcolm Baldrige National Quality Award in the manufacturing category, the top honor a U.S. company can achieve for business excellence. For more information please visit www.MEDRAD.com.
About CoSign®
The CoSign approach means digital signature standards and efficiencies across your operations. Signing and sealing documents with CoSign immediately expedites business processes, reduces costs, increases security and enables organizations to comply with diverse regional and industry regulations. CoSign works with all major applications and document formats including: Microsoft® Word, Excel®, Outlook®, Adobe® PDF, TIFF, AutoCAD®, InfoPath®, Lotus Forms, and many more). CoSign signatures are being used by hundreds of thousands of users in Enterprise, B2B and B2C processes, to learn why please see our white papers and product details at www.arx.com/products/cosign-digital-signatures.php
About ARX (Algorithmic Research)
ARX has over 20 years of experience assisting life sciences, healthcare, governmental, engineering, banking, financial services organizations and commercial sectors to secure and streamline their business processes and transactions. ARX offers a wide range of highly scalable products designed to simplify, secure, and accelerate electronic business. For more information, please visit www.arx.com
ARX, Inc.
855 Folsom Street
Suite 939
San Francisco, CA 94107
Tel: : (415) 839 8161
Fax : (415) 723 7110
Support : (925) 270 0992
E-mail: sales@arx.com
URL: http://www.arx.com
Founded in 1987, ARX (Algorithmic Research) is a worldwide provider of digital signatures (standard electronic signatures) and data-security solutions for financial, commercial, legal, and government sectors. ARX offers a wide range of high-end, state-of-the-art products and services designed to simplify, seal, secure, and accelerate digital transactions anytime, anywhere. The company specializes in designing and implementing quick-to-deploy and easy-to-use digital signature and security solutions.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release CoSign Digital Signatures to Expedite Field Service Reports at MEDRAD here
News-ID: 43752 • Views: …
More Releases from Arx, Inc.

ARX Practice Manager to Co-chair DIA Digital Signature Conference in May
ARX (Algorithmic Research), a leading provider of digital signature solutions (standard electronic signatures), announced today that Rodd Schlerf, the Life Science Practice Manager for ARX, will be co-chairing the Drug Information Association (DIA) Digital Signature Conference in Arlington, VA, on May 13, 2008. The event, “Digital Signatures: Practical Strategies for Life Science Organizations”, will focus on recent developments that remove obstacles like cost and complexity from the deployments of digital…

ARX Releases Version 4.4 of the CoSign Digital Signature Solution
ARX (Algorithmic Research), a leading global provider of digital signatures (standard electronic signatures), today announced the release of CoSign 4.4, the latest version from the fourth generation of the CoSign digital signature solution.
CoSign version 4.4 features new innovations including Web Services and support for Adobe’s Roaming ID. Web Services is an interface that allows digital signing in any application or programming language, making CoSign version 4.4 platform independent. Adobe Roaming…

CoSign Digital Signatures Make Workflow Takeoff at NAT
ARX (Algorithmic Research), a leading provider of digital signature (standard electronic signature) solutions, has implemented a CoSign® digital-signature solution at Northwest Aerospace Technologies (NAT), an engineering services company specializing in commercial aircraft modification programs.
Previous to their implementation of the CoSign digital signature solution, NAT's Engineering department routed a substantial number of paper drawings as part of their quality check process. Each drawing required up to 6 signatures and often needed…

CoSign Digital Signatures Automated Business Processes at Marrickville Council
ARX (Algorithmic Research), a leading provider of digital signature (standard electronic signature) solutions, and its Australian/New Zealand partner TME Digital Signature, have implemented a CoSign® digital signature solution at Marrickville Council, the local government council in the Inner West region of Sydney.
Previous to CoSign's implementation, Marrickville Council relied heavily on paper in its memo approval processes. The Council creates a significant number of memos each week focusing on a range…
More Releases for MEDRAD
Gadobutrol Market Overall Study Report 2024-2032 | Bayer, Guerbet, Shanghai Jiao …
The Gadobutrol Market research report offers crucial insights into how the industry is evolving, highlighting key drivers of growth and the main revenue streams expected between 2024 and 2032. It's like a compass guiding business through the complexities of the market, presenting not only the current landscape but also the latest innovations shaping its future. This report becomes a strategic ally for companies, stakeholders, and industry players, offering a comprehensive…
C-Arm Imaging Equipment Market will Witness Huge Growth till 2027 & Covid-19 Ana …
This C-Arm Imaging Equipment market research is presented through exceptional review about projections, industry growth factors, market competition, and suggestions to make organization lucrative and perception into goal marketplace. Identifying clear goal of the business is crucial enough for the enhancement of enterprise advancement and this illustrative market analysis helps to fix this goal and provides beneficial statistics. It presents the current state of enterprise and advises on how to…
Contrast Agent Market Size - Industry Growth Report, 2027| Bayer Healthcare Phar …
Complete study of the global Contrast Agent market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of the present as well as future scenario of the global Contrast Agent industry. Research techniques like PESTLE and Porter’s Five Forces analysis have been deployed by the researchers. They have also…
Angiography Injectors Market Business Opportunities 2026 - Top Companies are GE …
Global Angiography Injectors Market research Report 2019 may be a comprehensive business study on this state of business that analyses innovative ways for business growth and describes necessary factors like prime manufacturers, production worth, key regions and rate of growth. with growth trends, numerous stakeholders like investors, CEOs, traders, suppliers, analysis & media, international Manager, Director, President, SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization and others.…
Contrast Media Market 2019-2023 with GE Healthcare, Daiichi, Bayer Healthcare Ph …
Global Contrast Media Market - Key Players
GE Healthcare (US), Daiichi (Japan), Bayer Healthcare Pharmaceuticals (Germany), AMAG Pharmaceuticals (US), NanoScan Imaging (US), Medrad Inc (US), Targeson (US), Guerbet (Japan), Bracco Diagnostic Inc. (Italy), Guerbet Group (France), Covidien (Ireland), Lantheus Medical Imaging (U.S.), ), Bracco Imaging S.p.A. (Italy), Subhra Pharma Private Limited (India), nanoPET Pharma GmbH (Germany), CMC Contrast AB (Sweden), Mallinckrodt Pharmaceuticals (UK)
Global Contrast Media Market - Segmentation
By type, the Market…
Injectable Drug Delivery Devices Market Global Industry Analysis by 2024 – Med …
A fresh report has been added to the wide database of Business Industry Reports. The research study is titled “Injectable Drug Delivery Devices Market” by Manufacturers, Countries, Type and Application, Forecast to 2024 which provides important data about the production, consumption, revenue and company profiles for key industry participants.
Global Injectable Drug Delivery Devices Market Synopsis:
According to Market Analyst, Global Injectable Drug Delivery Devices Market is projected to grow at a…